Literature DB >> 25875614

Overlapping dopaminergic pathway genetic susceptibility to heroin and cocaine addictions in African Americans.

Orna Levran1, Matthew Randesi, Joel Correa da Rosa, Jurg Ott, John Rotrosen, Miriam Adelson, Mary Jeanne Kreek.   

Abstract

Drugs of abuse activate the mesolimbic dopaminergic pathway. Genetic variations in the dopaminergic system may contribute to drug addiction. Several processes are shared between cocaine and heroin addictions but some neurobiological mechanisms may be specific. This study examined the association of 98 single nucleotide polymorphisms in 13 dopamine-related genes with heroin addiction (OD) and/or cocaine addiction (CD) in a sample of 801 African Americans (315 subjects with OD ± CD, 279 subjects with CD, and 207 controls). Single-marker analyses provided nominally significant evidence for associations of 24 SNPs) in DRD1, ANKK1/DRD2, DRD3, DRD5, DBH, DDC, COMT and CSNK1E. A DRD2 7-SNPs haplotype that includes SNPs rs1075650 and rs2283265, which were shown to alter D2S/D2L splicing, was indicated in both addictions. The Met allele of the functional COMT Val158Met was associated with protection from OD. None of the signals remained significant after correction for multiple testing. The study results are in accordance with the results of previous studies, including our report of association of DRD1 SNP rs5326 with OD. The findings suggest the presence of an overlap in genetic susceptibility for OD and CD, as well as shared and distinct susceptibility for OD in subjects of African and European descent.
© 2015 John Wiley & Sons Ltd/University College London.

Entities:  

Keywords:  African Americans; COMT Val158Met; DRD1; DRD2; Dopaminergic pathway; cocaine addiction; heroin addiction; polymorphism; rs1075650; rs2283265; rs5326

Mesh:

Substances:

Year:  2015        PMID: 25875614      PMCID: PMC4399004          DOI: 10.1111/ahg.12104

Source DB:  PubMed          Journal:  Ann Hum Genet        ISSN: 0003-4800            Impact factor:   1.670


  59 in total

1.  Inference of population structure using multilocus genotype data.

Authors:  J K Pritchard; M Stephens; P Donnelly
Journal:  Genetics       Date:  2000-06       Impact factor: 4.562

2.  Addictions biology: haplotype-based analysis for 130 candidate genes on a single array.

Authors:  Colin A Hodgkinson; Qiaoping Yuan; Ke Xu; Pei-Hong Shen; Elizabeth Heinz; Elizabeth A Lobos; Elizabeth B Binder; Joe Cubells; Cindy L Ehlers; Joel Gelernter; John Mann; Brien Riley; Alec Roy; Boris Tabakoff; Richard D Todd; Zhifeng Zhou; David Goldman
Journal:  Alcohol Alcohol       Date:  2008-05-12       Impact factor: 2.826

3.  Stress-related genes and heroin addiction: a role for a functional FKBP5 haplotype.

Authors:  O Levran; E Peles; M Randesi; Y Li; J Rotrosen; J Ott; M Adelson; M J Kreek
Journal:  Psychoneuroendocrinology       Date:  2014-04-06       Impact factor: 4.905

Review 4.  Opiate addiction and cocaine addiction: underlying molecular neurobiology and genetics.

Authors:  Mary Jeanne Kreek; Orna Levran; Brian Reed; Stefan D Schlussman; Yan Zhou; Eduardo R Butelman
Journal:  J Clin Invest       Date:  2012-10-01       Impact factor: 14.808

5.  The D(2) dopamine receptor A(1) allele and opioid dependence: association with heroin use and response to methadone treatment.

Authors:  B R Lawford; R M Young; E P Noble; J Sargent; J Rowell; S Shadforth; X Zhang; T Ritchie
Journal:  Am J Med Genet       Date:  2000-10-09

6.  The ANKK1 protein associated with addictions has nuclear and cytoplasmic localization and shows a differential response of Ala239Thr to apomorphine.

Authors:  E Garrido; T Palomo; G Ponce; I García-Consuegra; M A Jiménez-Arriero; J Hoenicka
Journal:  Neurotox Res       Date:  2010-09-16       Impact factor: 3.911

7.  Intronic polymorphisms affecting alternative splicing of human dopamine D2 receptor are associated with cocaine abuse.

Authors:  Robert A Moyer; Danxin Wang; Audrey C Papp; Ryan M Smith; Linda Duque; Deborah C Mash; Wolfgang Sadee
Journal:  Neuropsychopharmacology       Date:  2010-12-08       Impact factor: 7.853

8.  Association between the catechol-O-methyltransferase Val158Met polymorphism and cocaine dependence.

Authors:  Falk W Lohoff; Andrew E Weller; Paul J Bloch; Aleksandra H Nall; Thomas N Ferraro; Kyle M Kampman; Helen M Pettinati; David W Oslin; Charles A Dackis; Charles P O'Brien; Wade H Berrettini
Journal:  Neuropsychopharmacology       Date:  2008-08-13       Impact factor: 7.853

9.  The dopamine receptor D1 gene is associated with the length of interval between first heroin use and onset of dependence in Chinese Han heroin addicts.

Authors:  Sufang Peng; Jiang Du; Haifeng Jiang; Yingmei Fu; Hanhui Chen; Haiming Sun; Dongxiang Wang; Shunying Yu; Min Zhao
Journal:  J Neural Transm (Vienna)       Date:  2013-05-10       Impact factor: 3.575

10.  Multivariate analysis of dopaminergic gene variants as risk factors of heroin dependence.

Authors:  Andrea Vereczkei; Zsolt Demetrovics; Anna Szekely; Peter Sarkozy; Peter Antal; Agnes Szilagyi; Maria Sasvari-Szekely; Csaba Barta
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

View more
  17 in total

1.  Glutamatergic and GABAergic susceptibility loci for heroin and cocaine addiction in subjects of African and European ancestry.

Authors:  Orna Levran; Einat Peles; Matthew Randesi; Joel Correa da Rosa; Jurg Ott; John Rotrosen; Miriam Adelson; Mary Jeanne Kreek
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2015-08-12       Impact factor: 5.067

2.  Casein kinase 1-epsilon deletion increases mu opioid receptor-dependent behaviors and binge eating1.

Authors:  L R Goldberg; S L Kirkpatrick; N Yazdani; K P Luttik; O A Lacki; R K Babbs; D F Jenkins; W E Johnson; C D Bryant
Journal:  Genes Brain Behav       Date:  2017-07-06       Impact factor: 3.449

3.  Dopamine gene variants in opioid addiction: comparison of dependent patients, nondependent users and healthy controls.

Authors:  Matthew Randesi; Wim van den Brink; Orna Levran; Vadim Yuferov; Peter Blanken; Jan M van Ree; Jurg Ott; Mary Jeanne Kreek
Journal:  Pharmacogenomics       Date:  2017-12-06       Impact factor: 2.533

4.  Synaptic Plasticity and Signal Transduction Gene Polymorphisms and Vulnerability to Drug Addictions in Populations of European or African Ancestry.

Authors:  Orna Levran; Einat Peles; Matthew Randesi; Joel Correa da Rosa; Jurg Ott; John Rotrosen; Miriam Adelson; Mary Jeanne Kreek
Journal:  CNS Neurosci Ther       Date:  2015-09-19       Impact factor: 5.243

Review 5.  RNA-binding proteins, neural development and the addictions.

Authors:  C D Bryant; N Yazdani
Journal:  Genes Brain Behav       Date:  2016-01       Impact factor: 3.449

6.  Effects of DRD2 splicing-regulatory polymorphism and DRD4 48 bp VNTR on crack cocaine addiction.

Authors:  Anderson R Stolf; Renata B Cupertino; Diana Müller; Breno Sanvicente-Vieira; Tatiana Roman; Eduardo S Vitola; Eugenio H Grevet; Lisia von Diemen; Felix H P Kessler; Rodrigo Grassi-Oliveira; Claiton H D Bau; Diego L Rovaris; Flavio Pechansky; Jaqueline B Schuch
Journal:  J Neural Transm (Vienna)       Date:  2018-10-26       Impact factor: 3.575

7.  Systems genetic analysis of binge-like eating in a C57BL/6J x DBA/2J-F2 cross.

Authors:  Emily J Yao; Richard K Babbs; Julia C Kelliher; Kimberly P Luttik; Kristyn N Borrelli; M Imad Damaj; Megan K Mulligan; Camron D Bryant
Journal:  Genes Brain Behav       Date:  2021-05-12       Impact factor: 3.708

8.  Validation Study of a Predictive Algorithm to Evaluate Opioid Use Disorder in a Primary Care Setting.

Authors:  Maneesh Sharma; Chee Lee; Svetlana Kantorovich; Maria Tedtaotao; Gregory A Smith; Ashley Brenton
Journal:  Health Serv Res Manag Epidemiol       Date:  2017-08-24

9.  Cocaine-induced adaptation of dopamine D2S, but not D2L autoreceptors.

Authors:  Brooks G Robinson; Alec F Condon; Daniela Radl; Emiliana Borrelli; John T Williams; Kim A Neve
Journal:  Elife       Date:  2017-11-20       Impact factor: 8.140

10.  A prospective, longitudinal study to evaluate the clinical utility of a predictive algorithm that detects risk of opioid use disorder.

Authors:  Ashley Brenton; Chee Lee; Katrina Lewis; Maneesh Sharma; Svetlana Kantorovich; Gregory A Smith; Brian Meshkin
Journal:  J Pain Res       Date:  2018-01-05       Impact factor: 3.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.